Article
A rare mutation in the COLQ gene causing congenital myasthenic syndrome with remarkable improvement to fluoxetine: A case report.
Neuromuscular disorders : NMD - 1 Mar 2021
Vidanagamage Anomali, Gooneratne Inuka Kishara, Nandasiri Shanika, Gunaratne Kamal, Fernando Arjuna, Maxwell Susan, Cossins Judith, Beeson David, Chang Thashi
Abstract excerpt
Congenital myasthenic syndromes (CMS) are genetically determined heterogenous disorders of neuromuscular transmission. We report a rare mutation of COLQ causing CMS in an Asian man that remarkably improved with fluoxetine. A 51-year-old Sri Lankan man with slowly progressive fatigable muscle weakness since eight years of age, presented with type 2 respiratory failure that required mechanical ventilation in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
